Differentiating COVID-associated heart failure from other Diseases: Difference between revisions
Jump to navigation
Jump to search
Line 56: | Line 56: | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pneumonia]] | |style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pneumonia]] | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |✔ ([[Pleuritic]]) | | style="background: #F5F5F5; padding: 5px;" |✔ ([[Pleuritic]]) | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ (Usually high) | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ | ||
| style="background: #F5F5F5; padding: 5px;" |✔ | | style="background: #F5F5F5; padding: 5px;" |✔ |
Revision as of 17:21, 20 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mitra Chitsazan, M.D.[2] Mandana Chitsazan, M.D. [3]
Overview
COVID-associated heart failure must be differentiated from other causes of dyspnea and/or hypoxia, including pneumonia, acute respiratory distress syndrome, myocarditis, and pulmonary embolism.
Differential Diagnosis
COVID-associated heart failure must be differentiated from pneumonia, acute respiratory distress syndrome, myocarditis, and pulmonary embolism.
Diseases | Symptoms | Physical Examination | Diagnostic tests | Other Findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dyspnea on Exertion | Chest Pain | Hemoptysis | Fever | Tachypnea | Tachycardia | Chest X-ray | ECG | Echocardiography> | CT scan and CMR | ||
COVID-19-associated heart failure | ✔ | - | ✔ | - | ✔ | ✔ |
|
|
|
|
Increased NT-proBNP and cardiac troponins levels |
COVID-19-associated pneumonia | ✔ | ✔ (Pleuritic) | ✔ | ✔ (Usually high) | ✔ | ✔ |
|
- | Increased inflammatory markers, including ESR, hs-CRP | ||
COVID-19-associated acute respiratory distress syndrome | ✔ | - | ✔ | ✔ | ✔ | ✔ |
|
- |
|
|
- |
COVID-19-associated myocarditis | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
|
|
|
Increased cardiac troponins level |
COVID-19-associated pulmonary embolism | ✔ (Usually sudden-onset) | ✔ (Pleauritic) | ✔ (If massive PE) | ✔ (Low-grade) | ✔ | ✔ |
|
|
|
|
|